Botulinum Toxin in the Treatment of Facial Paralysis

Omid B Mehdizadeh; Jacqueline Diels; William Matthew White

doi:10.1016/j.fsc.2015.09.008

Botulinum Toxin in the Treatment of Facial Paralysis

Facial Plast Surg Clin North Am. 2016 Feb;24(1):11-20. doi: 10.1016/j.fsc.2015.09.008.

Authors

Omid B Mehdizadeh¹, Jacqueline Diels², William Matthew White³

Affiliations

¹ NYU Langone Medical Center, 550 First Avenue - NBV 5E5, New York, NY 10016, USA.
² Facial Nerve Clinic, UW Hospitals and Clinics, 600 Highland Avenue, Madison, WI 53792, USA.
³ NYU Ambulatory Care Center, 240 E 38th Street, 14th Floor, New York, NY 10016, USA. Electronic address: William.white@nyumc.org.

PMID: 26611697
DOI: 10.1016/j.fsc.2015.09.008

Abstract

This article reviews the current literature supporting the use of botulinum toxin in producing symmetric facial features and reducing unwanted, involuntary movements. Methods, protocols, and adverse events are discussed. Additionally, the authors suggest that using botulinum toxin A therapy in postparalytic facial synkinesis can provide long-term results when used in conjunction with other treatment modalities.

Keywords: Asymmetry; Botulinum toxin; Facial paralysis; Synkinesis.

Publication types

Review

MeSH terms

Botulinum Toxins / therapeutic use*
Facial Paralysis / drug therapy*
Facial Paralysis / rehabilitation
Female
Humans
Male

Substances

Botulinum Toxins